Business & regional news

Month Year

Month Year

May 6, 2024

Medtronic receives approval for Symplicity Spyral™ Renal Denervation System in China

Symplicity Spyral is the first renal denervation technology to be approved by the National Medical Products Administration; new, innovative, minimally invasive procedure uses radiofrequency energy to help reduce high blood pressure
- Cardiovascular Diagnostics and Services
- Coronary and Renal Denervation
Mar 19, 2024

Medtronic receives Health Canada licence for the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ RF generator

Medtronic today announced it received a license from Health Canada for its Symplicity Spyral™ multi-electrode Renal Denervation (RDN) System. This is indicated for the management of essential...
- Cardiovascular Diagnostics and Services
- Coronary and Renal Denervation
Nov 28, 2023

First patient treated with Medtronic Symplicity Spyral™ renal denervation system at Piedmont
- Cardiovascular Diagnostics and Services
- Coronary and Renal Denervation
Oct 28, 2022

Study Finds Opportunity to Standardize Post-Stroke Pathways Among Academic and Community Hospitals

World Stroke Congress 2022: DiVERT Stroke Study shows significant differences in post-stroke workflow protocols and cardiac monitoring
- Cardiovascular Diagnostics and Services
Apr 28, 2022

New simulation data from the STROKE AF study shows insertable cardiac monitors detect 4 times more AF than intermittent monitoring

Heart Rhythm 2022: Sub-analysis indicates patients with intermittent monitoring may not be optimally managed for secondary stroke prevention
- Cardiovascular Diagnostics and Services
Apr 12, 2022

Medtronic announces upcoming market release of AI algorithms for cardiac monitoring in Europe

AccuRhythm AI algorithms shown to reduce false alerts by 84%
- Business News
- Cardiovascular Diagnostics and Services

Show per page